Key Record Dates
ClinicalTrials.gov Identifier: | NCT00360828 |
---|---|
Brief Title: | Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas |
First Submitted : | August 3, 2006 |
First Submitted that Met QC Criteria : | August 3, 2006 |
First Posted : | August 7, 2006 (Estimate) |
Results First Submitted : | October 3, 2011 |
Results First Submitted that Met QC Criteria : | November 7, 2011 |
Results First Posted : | December 9, 2011 (Estimate) |
Last Update Submitted that Met QC Criteria : | February 20, 2017 |
Last Update Posted : | March 23, 2017 |